The SMARTscreen Trial : a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program

dc.article.number31
dc.contributor.authorWood, Anna
dc.contributor.authorEmery, Jon D.
dc.contributor.authorJenkins, Mark
dc.contributor.authorChondros, Patty
dc.contributor.authorCampbell, Tina
dc.contributor.authorWenkart, Edweana
dc.contributor.authorO’Reilly, Clare
dc.contributor.authorCowie, Tony
dc.contributor.authorDixon, Ian
dc.contributor.authorMartínez Gutiérrez, Javiera
dc.date.accessioned2022-03-21T15:34:50Z
dc.date.available2022-03-21T15:34:50Z
dc.date.issued2022
dc.date.updated2022-01-16T01:03:11Z
dc.description.abstractBackground: Increasing participation in the Australian National Bowel Cancer Screening Program (NBCSP) is the most efficient and cost-effective way of reducing mortality associated with colorectal cancer by detecting and treating early-stage disease. Currently, only 44% of Australians aged 50–74 years complete the NBCSP. This efficacy trial aims to test whether this SMS intervention is an effective method for increasing participation in the NBCSP. Furthermore, a process evaluation will explore the barriers and facilitators to sending the SMS from general practice. Methods: We will recruit 20 general practices in the western region of Victoria, Australia to participate in a cluster randomised controlled trial. General practices will be randomly allocated with a 1:1 ratio to either a control or intervention group. Established general practice software will be used to identify patients aged 50 to 60 years old who are due to receive a NBCSP kit in the next month. The SMS intervention includes GP endorsement and links to narrative messages about the benefits of and instructions on how to complete the NBCSP kit. It will be sent from intervention general practices to eligible patients prior to receiving the NBCSP kit. We require 1400 eligible patients to provide 80% power with a two-sided 5% significance level to detect a 10% increase in CRC screening participation in the intervention group compared to the control group. Our primary outcome is the difference in the proportion of eligible patients who completed a faecal occult blood test (FOBT) between the intervention and control group for up to 12 months after the SMS was sent, as recorded in their electronic medical record (EMR). A process evaluation using interview data collected from general practice staff (GP, practice managers, nurses) and patients will explore the feasibility and acceptability of sending and receiving a SMS to prompt completing a NBCSP kit. Discussion: This efficacy trial will provide initial trial evidence of the utility of an SMS narrative intervention to increase participation in the NBCSP. The results will inform decisions about the need for and design of a larger, multi-state trial of this SMS intervention to determine its cost-effectiveness and future implementation.
dc.format.extent14 páginas
dc.fuente.origenAutoarchivo
dc.identifier.citationTrials. 2022 Jan 12;23(1):31
dc.identifier.doi10.1186/s13063-021-05877-3
dc.identifier.urihttps://doi.org/10.1186/s13063-021-05877-3
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/63595
dc.information.autorucEscuela de Medicina ; Martínez Gutiérrez, Javiera ; 0000-0002-2493-9974 ; 18421
dc.language.isoen
dc.nota.accesoContenido completo
dc.pagina.final14
dc.pagina.inicio1
dc.revistaTrials
dc.rightsacceso abierto
dc.rights.holderThe Author(s)
dc.subjectColorectal cancer screeninges_ES
dc.subjectBowel canceres_ES
dc.subjectGeneral practicees_ES
dc.subjectHealth promotiones_ES
dc.subjectNational Bowel Canceres_ES
dc.subjectScreening Programes_ES
dc.subject.ddc616.994347
dc.subject.deweyMedicina y saludes_ES
dc.titleThe SMARTscreen Trial : a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Programes_ES
dc.typeartículo
dc.volumen23
sipa.codpersvinculados18421
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
13063_2021_Article_5877.pdf
Size:
1.66 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: